Global Vaccine Adjuvants Market Size is projected to grow at a CAGR of 10.1% by 2023 | Industry Analysis, Growth, Opportunities

Vaccine Adjuvants Market Information: By Type (Pathogen Components, Particulate Adjuvants, others), By Route of Administration (Oral, Intramuscular, Subcutaneous, and Intradermal), and By End Users (Pediatric, Adult) - Global Forecast Till 2023

Pune, India - April 15, 2019 /MarketersMedia/ —

Market Overview:

Vaccine adjuvant is formulated as a component of vaccine which enhances the effectiveness of vaccine and its ability to protect against infections. Adjuvant aids in activating the immune system which in turn provides the body with long-term protective immunity against various types of infections and diseases. Market Research Future (MRFR) has recently published a report asserting that the global vaccine adjuvants market is marked to expand at a noteworthy CAGR of 10.1% during the forecast period of 2017-2023.

Market Drivers and Restraints:

Rise in prevalence of various diseases that directly attack the immune system of human beings has led to the increased demand for vaccines all over the world., which in turn is propelling the growth of the global vaccine adjuvants market. The ability of adjuvants to enhance the effectiveness of vaccines and increased research and development for introducing high-quality vaccines are some other factors that are fueling the expansion of the global vaccine adjuvants market. However, low penetration of advanced healthcare solutions, low research and development expenditure in underdeveloped regions and lack of awareness in these regions are likely to restrain the growth of the global vaccine adjuvants market during the assessment period.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/1098

Market Segmentation:

The global vaccine adjuvants market has been are segmented on the basis of types, routes of administration, and end users. Based on types, the vaccine adjuvants market has been segmented into pathogen components, particulate adjuvants, and others. The particulate adjuvants segment is dominating the global vaccine adjuvants market owing to the presence of large variety of products and its greater efficiency in the treatment of diseases. Based on routes of administration, the vaccine adjuvants market has been segmented into oral, intramuscular, subcutaneous, and intradermal. The intramuscular segment commanded for the major share in the global vaccine adjuvants market as this route of administration of vaccines provide better immune specificity. Based on end users, the vaccine adjuvants market has been segmented into pediatric, adult.

Regional Analysis:

Geographically, the global vaccine adjuvants market has been segmented into four major regions such as the America, Asia Pacific, Europe, and the Middle East and Africa. The Americas command for the major share in the global vaccine adjuvants market owing to the high demand for vaccines, increased healthcare expenditure and increased utilization of advanced technology for the development of advanced medications in the well-developed healthcare infrastructure in this region. The Europe region commands for the second largest share in the global vaccine adjuvants market owing to the research and development activities carried out in the biotechnological and pharmaceutical industries for introducing highly effective vaccines to tackle various diseases and increased healthcare expenditure by the population of this region. The Asia Pacific region is projecting fastest growth in the global vaccine adjuvants market owing to the increased prevalence of contagious diseases and improvement in the healthcare sector of emerging economies like India and China in this region. Lack of awareness and low penetration of primary healthcare solutions are leading to the slow growth of the vaccine adjuvants market in the Middle East and Africa region.

Competitive Analysis:

With the help of advanced technology, the players in the global vaccine adjuvants market are focusing on business expansion by developing advanced products for creating highly effective vaccines. Strategic mergers and acquisitions are aiding these players to sustain the competitive environment of the global vaccine adjuvants market.

The leading players profiled by MRFR that are operating in the global vaccine adjuvants market are VaxLiant LLC.(the U.S), Vaxine Pty Ltd (Australia), Aphios Corporation (the U.S), Viscogel AB (Sweden), Adjuvatis (France), Sergeant Adjuvants (the U.S), Sigma-Aldrich Co. LLC.(India), CureVac AG (Germany), Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (the U.S), Novavax, Inc.(the U.S), SPI Pharma, Inc.(the U.S), Invivogen (the U.S), Avanti Polar Lipids, Inc. (the U.S), MPV Technologies (the U.S), and OZ Biosciences (France).

Get full report & TOC @: https://www.marketresearchfuture.com/reports/vaccine-adjuvants-market-1098

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Email: Send Email
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com

Source URL: https://marketersmedia.com/global-vaccine-adjuvants-market-size-is-projected-to-grow-at-a-cagr-of-101-by-2023-industry-analysis-growth-opportunities/502724

Source: MarketersMedia

Release ID: 502724

Latest News

House Democrats wrestle with White House over investigations

Apr 24, 2019

WASHINGTON — The struggle between House Democrats and the Trump administration over investigations intensified as a former White House official defied a subpoena and the Treasury Department ignored a deadline for providing President Donald Trump's tax returns. Rep. Elijah Cummings, the chairman of the House Oversight Committee, said the White House has adopted the "untenable" position that it can ignore requests from the Democratic majority in the House. "It appears that the president believes that the Constitution does not apply to his White House, that he may order officials at will to violate their legal obligations, and that he may...

Caterpillar: 1Q Earnings Snapshot

Apr 24, 2019

DEERFIELD, Ill. — Caterpillar Inc. on Wednesday reported first quarter net income of $1.88 billion. The Deerfield, Illinois-based company said it had net income of $3.25 per share. Earnings, adjusted for non-recurring gains, came to $2.94 per share. The results beat Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $2.84 per share. The construction equipment company posted revenue of $13.47 billion in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $13.4 billion. Caterpillar expects full-year earnings in the range of $11.75 to $12.75 per share....

The name on the back matters: NHL is now marketing its stars

Apr 24, 2019

Connor McDavid is eager to shrug off personal stats, awards and achievements and put the focus on his team in Edmonton. Yet there he is on the cover of a video game or in a commercial for a bank. Auston Matthews is the face of the franchise in Toronto. But he also got razzed by his Maple Leafs teammates for doing a stylish fashion photo shoot for GQ magazine. "It was a lot of fun," Matthews said. "Kind of something that definitely got you out of your comfort zone." The rink for long decades has been the comfort zone for...

Former Barcelona president acquitted of money laundering

Apr 24, 2019

MADRID — Former Barcelona president Sandro Rosell has been acquitted of money laundering charges after spending nearly two years in prison. Court officials in Madrid said Wednesday there was not enough evidence for a guilty verdict on charges related to the sale of television rights for matches involving the Brazilian national soccer team. Rosell was in custody for nearly 22 months after being accused of misappropriating funds coming from the sale of TV rights and the organization of friendly matches featuring Brazil as well as from a sponsorship contract between Nike and Brazil. Spanish prosecutors were initially seeking an 11-year...

World stocks subdued as Wall Street eyes new record highs

Apr 24, 2019

BANGKOK — Stock markets were subdued in Europe and Asia on Wednesday as investors look to corporate earnings for clues on whether the S&P 500 will hit another all-time record close. The FTSE 100 in Britain lost 0.3% to 7,502 while the CAC 40 in France was flat at 5,590. The DAX in Germany gained 0.8% to 12,336. On Wall Street, the future contract for the Dow was up 0.1% while the S&P 500 future contract was roughly flat. The lackluster start for the day followed news that a U.S. delegation will visit Beijing next week to continue trade negotiations....

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com